The purpose of this study is to compare the pharmacokinetics and pharmacodynamics behavior of the two formulation of QLC7401 injection to further evaluate the effect of the production site change.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Cmax
Timeframe: 0.25, 0.5, 1, 2, 4, 6, 8, 12, 24, 48 hours post dose
AUC
Timeframe: 0.25, 0.5, 1, 2, 4, 6, 8, 12, 24, 48 hours post dose
Tmax
Timeframe: 0.25, 0.5, 1, 2, 4, 6, 8, 12, 24, 48 hours post dose
t1/2
Timeframe: 0.25, 0.5, 1, 2, 4, 6, 8, 12, 24, 48 hours post dose
CL/F
Timeframe: 0.25, 0.5, 1, 2, 4, 6, 8, 12, 24, 48 hours post dose
VZ/F
Timeframe: 0.25, 0.5, 1, 2, 4, 6, 8, 12, 24, 48 hours post dose